Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
David W. Andrews(Seoul National University), Walter J. Curran(Piedmont Cancer Institute), Charles Scott(American College of Radiology), Minesh P. Mehta(Columbia University), Paul W. Sperduto(Methodist Hospital), William F. Demas(Summa Health System), Jean-Paul Bahary(Université de Montréal), Maria Werner‐Wasik(American College of Radiology), Laurie E. Gaspar(University of Colorado Cancer Center), Janice Ryu(University of California Davis Medical Center), Michael C. Schell(University of Rochester), Adam E. Flanders(Jefferson University Hospitals), Marvin Rotman(SUNY Downstate Health Sciences University), Luís Souhami(McGill University Health Centre)
Cited by 2,424
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k
BCL-2 family proteins: changing partners in the dance towards death
|Cell Death and Differentiation|2017|1.6k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k